129 related articles for article (PubMed ID: 6102232)
1. End-organ resistance to 1,25-dihydroxycholecalciferol.
Liberman UA; Samuel R; Halabe A; Kauli R; Edelstein S; Weisman Y; Papapoulos SE; Clemens TL; Fraher LJ; O'Riordan JL
Lancet; 1980 Mar; 1(8167):504-6. PubMed ID: 6102232
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D.
Beer S; Tieder M; Kohelet D; Liberman OA; Vure E; Bar-Joseph G; Gabizon D; Borochowitz ZU; Varon M; Modai D
Clin Endocrinol (Oxf); 1981 Apr; 14(4):395-402. PubMed ID: 6266702
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D.
Kudoh T; Kumagai T; Uetsuji N; Tsugawa S; Oyanagi K; Chiba Y; Minami R; Nakao T
Eur J Pediatr; 1981 Nov; 137(3):307-11. PubMed ID: 7318845
[TBL] [Abstract][Full Text] [Related]
4. Rickets with alopecia-remission following a course of 1-alpha-hydroxy vitamin D3 therapy.
Manandhar DS; Sarkawi S; Hunt MC
Eur J Pediatr; 1989 Aug; 148(8):761-3. PubMed ID: 2551693
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and vitamin D dependency.
Tsuchiya Y; Matsuo N; Cho H; Tsubouchi K; Kumagai M; Nishii Y; Nanjoh M; Yamamoto T
Contrib Nephrol; 1980; 22():89-100. PubMed ID: 6967387
[TBL] [Abstract][Full Text] [Related]
6. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects.
Balsan S; Garabedian M; Liberman UA; Eil C; Bourdeau A; Guillozo H; Grimberg R; Le Deunff MJ; Lieberherr M; Guimbaud P; Broyer M; Marx SJ
J Clin Endocrinol Metab; 1983 Oct; 57(4):803-11. PubMed ID: 6309886
[TBL] [Abstract][Full Text] [Related]
7. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D.
Tsuchiya Y; Matsuo N; Cho H; Kumagai M; Yasaka A; Suda T; Orimo H; Shiraki M
J Clin Endocrinol Metab; 1980 Oct; 51(4):685-90. PubMed ID: 6252222
[TBL] [Abstract][Full Text] [Related]
8. 1 alpha-hydroxyvitamin D3 treatment of three patients with 1,25-dihydroxyvitamin D-receptor-defect rickets and alopecia.
Takeda E; Kuroda Y; Saijo T; Naito E; Kobashi H; Yokota I; Miyao M
Pediatrics; 1987 Jul; 80(1):97-101. PubMed ID: 3037475
[TBL] [Abstract][Full Text] [Related]
9. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D.
Brooks MH; Bell NH; Love L; Stern PH; Orfei E; Queener SF; Hamstra AJ; DeLuca HF
N Engl J Med; 1978 May; 298(18):996-9. PubMed ID: 205789
[TBL] [Abstract][Full Text] [Related]
10. Alopecia with rickets: an end organ unresponsiveness to 1,25-dihydroxyvitamin D--a case report.
Gupta PC; Patwari AK; Mullick DN
Indian J Med Sci; 1990 Sep; 44(9):239-43. PubMed ID: 2269515
[TBL] [Abstract][Full Text] [Related]
11. Effect of 1alpha-hydroxycholecalciferol, 1,25-dihydroxycholecalciferol, 3 deoxy-1alpha-hydroxycholecalciferol, 24R, 25-dihydroxycholecalciferol and successful renal transplantation on calcium absorption in haemodialysis patients.
Pierides AM; Aljama P; Kerr DN; Scott M; Norman AW
Nephron; 1978; 20(4):203-11. PubMed ID: 345140
[TBL] [Abstract][Full Text] [Related]
12. Determination of circulating 25,26-dihydroxycholecalciferol in man by radioimmunoassay.
Fraher LJ; Clemens TL; Papapoulos SE; Redel J; O'Riordan JL
Clin Sci (Lond); 1980 Oct; 59(4):257-63. PubMed ID: 7428293
[TBL] [Abstract][Full Text] [Related]
13. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Balsan S; Garabedian M; Sorgniard R; Holick MF; Deluca HF
Pediatr Res; 1975 Jul; 9(7):586-93. PubMed ID: 169507
[TBL] [Abstract][Full Text] [Related]
14. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
[TBL] [Abstract][Full Text] [Related]
15. Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell cultures.
Spanos E; Barrett DI; Chong KT; MacIntyre I
Biochem J; 1978 Jul; 174(1):231-6. PubMed ID: 697754
[TBL] [Abstract][Full Text] [Related]
16. Serum 1,25-dihydroxyvitamin D levels in normal subjects and in patients with hereditary rickets or bone disease.
Scriver CR; Reade TM; DeLuca HF; Hamstra AJ
N Engl J Med; 1978 Nov; 299(18):976-9. PubMed ID: 308618
[TBL] [Abstract][Full Text] [Related]
17. Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.
Seino Y; Ishii T; Shimotsuji T; Ishida M; Yabuuchi H
Arch Dis Child; 1981 Aug; 56(8):628-32. PubMed ID: 6973954
[TBL] [Abstract][Full Text] [Related]
18. Measurement of vitamin D metabolites in anephric subjects.
Jongen MJ; van der Vijgh WJ; Lips P; Netelenbos JC
Nephron; 1984; 36(4):230-4. PubMed ID: 6608697
[TBL] [Abstract][Full Text] [Related]
19. Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.
Chertow BS; Baylink DJ; Wergedal JE; Su MH; Norman AW
J Clin Invest; 1975 Sep; 56(3):668-78. PubMed ID: 1159080
[TBL] [Abstract][Full Text] [Related]
20. Mediation of calcium adaptation by 1,25-dihydroxycholecalciferol.
Omdahl JL; DeLuca HF
J Nutr; 1977 Nov; 107(11):1975-80. PubMed ID: 908954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
